arrow
Z

Zahra Shirzadi

Harvard Medical School
H指数:21
被引数:1,396

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease

身体活动作为临床前期阿尔茨海默病的可改变风险因素

2025-11-030
OAAI
Independent effects of white matter lesion volume and APOE ɛ4 on ARIA-H in A4 Study

A4研究中白质病变体积和APOE ɛ4对ARIA-H的独立影响

2025-10-140
OAAI
Estimating the preclinical Alzheimer's disease course with multimodal data

利用多模态数据估算临床前阿尔茨海默病病程

2025-09-030
OAAI
Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease

更大的白质高强度体积与临床前阿尔茨海默氏病的微出血数量有关

2024-08-010
PRE
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration

从横截面淀粉样蛋白,tau和神经变性中识别纵向认知弹性

2024-07-030
OAAI
Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard aging brain study
2024-03-073
PRE
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
2024-02-211
OA
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease

血浆VEGFA和PGF影响临床前阿尔茨海默病的纵向tau和认知

BRAIN
IF11.7
2024-02-056
PRE
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease
2023-06-084
OAAI
Detecting Silent Acute Microinfarcts in Cerebral Small Vessel Disease Using Submillimeter Diffusion-Weighted Magnetic Resonance Imaging: Preliminary Results

使用亚毫米扩散加权磁共振成像检测脑小血管疾病中的无症状急性微梗死: 初步结果

STROKE
IF8.9
2022-07-013
OA
Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy
2022-06-2513
OA